The fibrolamellar variant of hepatocellular carcinoma is an uncommon tumour which has distinctive clinical and histological features. No risk factors have yet been identified, and in particular it does not appear to be predisposed to by cirrhosis or infection with the hepatitis B virus. ' Hepatobiliary carcinoma is a well described complication of ulcerative colitis and primary sclerosing cholangitis." In the numerous reported cases, however, the histological diagnosis has almost invariably been cholangiocarcinoma.' We report the first documented case of fibrolamellar hepatocellular carcinoma developing in a patient with chronic ulcerative colitis complicated by primary sclerosing cholangitis. 
